DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
This Quarter Return
+1.37%
1 Year Return
-10.85%
3 Year Return
+35.19%
5 Year Return
+71.7%
10 Year Return
AUM
$1.21B
AUM Growth
+$1.21B
Cap. Flow
-$7.37M
Cap. Flow %
-0.61%
Top 10 Hldgs %
24.8%
Holding
309
New
15
Increased
120
Reduced
146
Closed
4

Sector Composition

1 Technology 14.23%
2 Healthcare 13.23%
3 Financials 11.24%
4 Consumer Staples 10.22%
5 Consumer Discretionary 7.03%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ADMS
301
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$66K 0.01%
+13,000
New +$66K
VTAK icon
302
Catheter Precision
VTAK
$3.12M
$48K ﹤0.01%
34,250
+4,000
+13% -$110K
FBIO icon
303
Fortress Biotech
FBIO
$87.8M
$28K ﹤0.01%
20,000
CBL
304
DELISTED
CBL& Associates Properties, Inc.
CBL
$13K ﹤0.01%
+10,000
New +$13K
ATNM icon
305
Actinium Pharmaceuticals
ATNM
$53.3M
$5K ﹤0.01%
22,870
APC
306
DELISTED
Anadarko Petroleum
APC
-23,579
Closed -$1.66M
VOE icon
307
Vanguard Mid-Cap Value ETF
VOE
$18.6B
-1,854
Closed -$206K
FBRX icon
308
Forte Biosciences
FBRX
$138M
-17,122
Closed -$114K
DXC icon
309
DXC Technology
DXC
$2.6B
-3,664
Closed -$202K